Kim L. Dueholm

Kim Dueholm is a Partner in Novo Ventures, Novo A/S.

Kim Dueholm joined Novo A/S in 2000. He is a member of the board of directors of f-star GmbH and Novexel S.A., and a former director of Core A/S, Neurokey A/S, Nuevolution A/S and Symphogen A/S, and is a member of the editorial board of Expert Opinion on Therapeutic Patents.

Prior to joining Novo A/S, Kim spent five years with Novo Nordisk A/S in positions ranging from Patent Portfolio Analyst to Principal Scientific Analyst. His international experience includes research and venture fund experience in California, USA, and research experience in Osaka, Japan.

Kim is an intellectual property expert and holds a PhD in organic chemistry from the University of Copenhagen and an MSc in chemistry/business administration from Odense University.